SCHEMBL4894623

SCHEMBL4894623

NCCc1csc(-c2ccc(F)cc2F)n1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALPL P05186 1/20 0.40
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
IDO1 P14902 1/20 0.38
AGER Q15109 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900754 0.86 LMNA (0.45) LMNASMN1; SMN2MAOAMAOBALDH1A1
SCHEMBL13181067 0.86 SREBF2 (0.47) LMNASMN1; SMN2MAOAMAOBALDH1A1
SCHEMBL3093212 0.83 KDM4E (0.43) LMNASMN1; SMN2MAOAMAOBALDH1A1
SCHEMBL6477011 0.83 ALDH1A1 (0.51) LMNASMN1; SMN2MAOAMAOBALDH1A1
SCHEMBL15014149 0.83 MAPT (0.45) LMNASMN1; SMN2MAOAMAOBALDH1A1
SCHEMBL2228478 0.81 LMNA (0.59) LMNAMAOBALDH1A1HPGDL3MBTL1
SCHEMBL5717729 0.80 LMNA (0.51) LMNASMN1; SMN2ALDH1A1HPGDTP53
SCHEMBL13153207 0.79 LMNA (0.42) LMNASMN1; SMN2MAOAMAOBALDH1A1
SCHEMBL4876855 0.77 ALDH1A1 (0.41) SMN1; SMN2MAOAMAOBALDH1A1MAPT
SCHEMBL3470993 0.76 LMNA (0.50) LMNASMN1; SMN2ALDH1A1POLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885SMN1; SMN2 3271/4885MAOA 4248/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885SMN1; SMN2 3404/4885MAOA 4248/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885SMN1; SMN2 3404/4885MAOA 4248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.